ResMed | RMD - Kısa Vadeli Yükümlülükler





Kısa Vadeli Yükümlülükler Değişiklik Tarih
Ansell USD 468.9M 53.1M 2025-12
Artivion USD 76.66M 30.28M 2026-09
AtriCure USD 83.97M 2.06M 2026-09
Baxter International USD 3.81B 218M 2026-09
Cochlear AUD 558.9M 43.4M 2025-12
Cooper Companies USD 1.87B 61.9M 2026-06
CSL USD 4.61B 207M 2025-12
Dexcom USD 2.25B 105.1M 2026-09
Edwards Lifesciences USD 1.58B 68.8M 2026-09
Fisher Paykel Healthcare NZD 497.8M 26.5M 2026-06
Globus Medical USD 507.94M 28.59M 2026-09
Haemonetics USD 300.84M 37.6M 2026-09
Idexx Laboratories USD 1.26B 23.44M 2026-09
Inogen USD 64.94M 2.12M 2025-09
Insulet USD 814.4M 70.2M 2026-09
Integra LifeSciences USD 329M 1.88M 2026-09
Intuitive Surgical USD 3.23B 652.4M 2026-09
Medtronic USD 11.8B 141M 2026-06
Philips EUR 7.91B 485M 2026-09
Ramsay Health Care AUD 3.95B 514.2M 2025-12
ResMed USD 1.32B 70.89M 2026-09
Sigma Healthcare AUD 1.7B 1.33B 2025-12
Sonic Healthcare AUD 2.23B 92.84M 2024-12
Steris USD 1.21B 75.5M 2026-09
Teleflex USD 917.1M 196.72M 2026-09
Thermo Fisher Scientific USD 14.17B 899M 2026-09